Salón de Grados, Edificio Politécnico, MOLAB, 11:30h.

Pablo Menéndez

ICREA Research Professor

Josep Carreras Leukaemia Research Institute, Barcelona, Spain

I will briefly introduce CAR-T therapy and show the latest work (published and still in development) with new CART targets, new allogeneic effector cells and T cell engager release models. Finally I will show scRNA and scTCR data in longitudinal samples of patients treated with CARTs.